TECENTRIQ HYBREZA

ATEZOLIZUMAB AND HYALURONIDASE-TQJS · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TECENTRIQ HYBREZA, covering 2024-09-12 to 2025-11-24. Get the full timeline:

Most recent: FDA Approved: TECENTRIQ HYBREZA — Supplemental Application (Genentech, Inc.)